文献速递间质性肺疾病

法国系统性红斑狼疮间质性肺病的10年全国人群流行病学研究

Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation-wide population-based study over 10 years.
PubMed 文献 · Respirology · 2022-04-21

该研究利用法国全国医疗行政数据库,分析2011至2012年住院的10,460例系统性红斑狼疮(SLE)患者,其中134例(1.2%)基线诊断间质性肺病(ILD)。多变量分析显示ILD与SLE患者死亡风险增加相关(HR 1.992,95%CI 1.420-2.794,p<0.0001)。在31,029例基线无ILD的SLE患者中,2013至2020年ILD发生率为10.26/1000患者年(95%CI 10.24-10.28)。

要点

  • SLE患者中ILD患病率1.2%,发生率10.26/1000患者年。
  • 合并其他自身免疫病(如干燥综合征、系统性硬化)者ILD频率更高(29.9% vs 5.9%)。
  • ILD是SLE患者死亡的独立危险因素(HR 1.992)。

核心结论

  • SLE中ILD极其罕见,常与另一种系统性自身免疫病相关,且是死亡的主要危险因素。

研究设计与样本

  • 基于法国国家医疗行政数据库的全国性人群研究,纳入2011至2012年住院的10,460例SLE患者并随访至2020年。
  • 采用Cox风险模型评估ILD对生存的影响,并通过2013至2020年新发ILD分析估算发病率。

主要发现

  • 2011至2012年,10,460例SLE住院患者中134例(1.2%)基线诊断ILD。
  • 合并干燥综合征或系统性硬化等自身免疫病者ILD频率为29.9%,无合并者为5.9%(p<0.0001)。
  • 多变量分析显示ILD与死亡风险增加相关,风险比(95%CI)为1.992(1.420-2.794),p<0.0001。
  • 31,029例基线无ILD的SLE患者中,2013至2020年795例(2.6%)发生ILD。
  • SLE中ILD的发病率为10.26/1000患者年(95%CI 10.24-10.28)。

临床怎么用

  • 对SLE患者应警惕ILD发生,尤其合并其他系统性自身免疫病者。
  • SLE患者一旦诊断ILD,需评估死亡风险并加强管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Data regarding interstitial lung disease (ILD) in the setting of systemic lupus erythematosus (SLE) are limited. We used a nationwide database to determine the incidence and the prevalence of ILD in SLE. METHODS: Characteristics of all SLE inpatients admitted between 2011 and 2012 in France were analysed through the French medico-administrative database. Features associated with the presence of ILD were studied. Cox hazard model was used to measure the impact of ILD on survival from the first stay to 2020. The incidence of ILD in SLE was estimated by analysing the onset of ILD from 2013 to 2020 in SLE patients who had no evidence of ILD in 2013. RESULTS: Between 2011 and 2012, 10,460 SLE patients had at least one hospital stay and could be traced until 2020. Among them, 134 (1.2%) had an ILD diagnosed at baseline. The frequency of ILD in SLE was higher in patients who had an associated autoimmune disease such as Sjögren's syndrome or systemic sclerosis (29.9% vs. 5.9%, p < 0.0001). ILD was associated with an increased risk of death in SLE in the multivariable analysis (hazard ratio [95% CI] 1.992 [1.420-2.794]; p < 0.0001). Among the 31,029 SLE patients with no evidence of ILD at baseline, ILD occurred in 795 (2.6%) between 2013 and 2020. The incidence rate of ILD in SLE was 10.26 for 1000 patient-years [95% CI: 10.24-10.28]. CONCLUSION: In SLE, ILD is exceedingly rare, often associated with another systemic autoimmune disorder and appears as a major risk factor for death.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Mageau A, Borie R, Crestani B, et al. Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation-wide population-based study over 10 years. Respirology. 2022. PMID: 35446457. doi:10.1111/resp.14268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。